Table 1. Baseline characteristics according to incident abnormal uterine bleeding (AUB).
Values are presented as mean±SD, median (IQR), or n (%), as appropriate.
t=independent-samples t-test statistic; χ²=Pearson chi-square statistic; Z=standardized Mann-Whitney test statistic; AUB=abnormal uterine bleeding; BMI=body mass index; HbA1c=glycated hemoglobin; LDL-C=low-density lipoprotein cholesterol; HDL-C=high-density lipoprotein cholesterol; PCOS=polycystic ovary syndrome
| Characteristic | AUB (n=45) | No AUB (n=105) | Test statistic | P value |
| Age, years | 44.6±6.3 | 42.8±6.7 | t=1.57 | 0.119 |
| BMI, kg/m² | 31.7±4.9 | 28.9±4.7 | t=3.25 | 0.002 |
| BMI ≥30 kg/m² | 27 (60.0%) | 42 (40.0%) | χ²=5.07 | 0.024 |
| Diabetes duration, years | 9.3±4.8 | 7.1±4.4 | t=2.64 | 0.010 |
| HbA1c, % | 8.8±1.3 | 7.9±1.2 | t=3.97 | <0.001 |
| HbA1c ≥8.5% | 29 (64.4%) | 38 (36.2%) | χ²=10.17 | 0.001 |
| Fasting glucose, mg/dL | 181±42 | 159±37 | t=3.04 | 0.003 |
| Total cholesterol, mg/dL | 201±39 | 189±37 | t=1.79 | 0.075 |
| LDL-C, mg/dL | 122±33 | 116±31 | t=1.04 | 0.302 |
| HDL-C, mg/dL | 41.3±8.1 | 45.2±8.6 | t=−2.65 | 0.009 |
| Triglycerides, mg/dL | 194 (158-238) | 164 (132-203) | Z=2.88 | 0.004 |
| Hypertension | 21 (46.7%) | 36 (34.3%) | χ²=2.05 | 0.152 |
| PCOS | 10 (22.2%) | 11 (10.5%) | χ²=3.61 | 0.057 |
| Insulin treatment | 17 (37.8%) | 28 (26.7%) | χ²=1.85 | 0.174 |
| Metformin treatment | 35 (77.8%) | 87 (82.9%) | χ²=0.54 | 0.464 |